New insight in perivenular lesion formation in multiple sclerosis on weekly susceptibility weighted images
Simon Mure1, Charles Guttmann2, Thomas Grenier1, Hugues Benoit-Cattin1, and François Cotton3

1CREATIS, Villeurbanne cedex, France, 2Center for Neurological Imaging, Brigham and Women's Hospital, Boston, MA, United States, 3CREATIS - HCL, Villeurbanne cedex, France

Synopsis

In this paper, we take advantage of a unique longitudinal MRI dataset acquired at weekly intervals on untreated multiple sclerosis patients. We study the signal dynamics of relapsing-remitting multiple sclerosis lesions on SWI MRI and show, thanks to an unsupervised spatiotemporal clustering algorithm, that specific signal intensity behaviors exist between the veins and the lesions that are synchronous with contrast enhancement on gadolinium-enhanced T1-weighted MRI. Our study shows that vein narrowing depicted on SWI is an early event that appears to precede blood-brain barrier disruption signified by contrast-enhancement.

PURPOSE

Multiple sclerosis (MS) is a disease of the central nervous system characterized by spatial and temporal dissemination of demyelination, axonal loss, and gliosis. It is the primary cause of non-traumatic disability in young patients, and its exact pathophysiology remains unknown. Characteristically, lesions in the white matter develop around a central vein1.

Susceptibility-weighted imaging (SWI) can directly depict cerebral veins by exploiting venous blood oxygenation2. No study has presented the dynamic interaction between the veins and the occurrence and early evolution of new lesions in MS. We describe dynamic changes in appearance of both the central vein and the surrounding new lesions in a unique cohort of patients followed at weekly intervals with a multimodal MR protocol3,4.

Furthermore, we use an automated analysis method5 to quantify the observed dynamic changes in the central vein.

METHODS

Five untreated relapsing-remitting MS patients underwent 8 weekly 3T MR acquisitions4. New lesions were detected on gadolinium-enhanced T1-weighted MRI as well as on SWI MRI. SWI was used to describe changes in the appearance of lesion and central vein during lesion formation.

Selection criteria for studied MS lesions: (1) Contrast-enhancement appears after the baseline acquisition and is no longer visible at the 8th time-point, to ensure complete history of enhancement; (2) The veins on which the lesions are centred must have a minimal diameter of 2 pixels.

The selected SWI ROIs were processed with an unsupervised spatiotemporal clustering method5 in order to group pixels sharing similar intensity evolution patterns. No prior knowledge about data behavior was used to initialize or guide the analysis.

RESULTS

101 lesions out of 212 active lesions were enhancing after baseline and no longer enhancing at week 8. Out of these, only three new enhancing lesions in 2 of the 5 patients met the full inclusion criteria, enabling their characterization. In all three lesions transient hyperintensity was observed on SWI within the central vein at the time of enhancement. The automatic clustering obtained on each ROI identified several evolution patterns within the lesions, with one occurring at the lesion core between the veins and the white matter as shown in Fig. 1.

Moreover, it is shown in Figures 2, 3 and 4 that the specific grey level behaviors at the vein/lesion (V/L) interface occur either simultaneously to the lesion enhancement (ROI A) or before lesion enhancement in the SWI acquisitions (ROI B, C). These observations show the centrifugal development around a central vein of the observed MS lesions on highly resolved temporal data, which is consistent with previous work6.

DISCUSSION

The development of MS lesions around the vein was observed in histology long time ago especially by7,8. They first hypothesised a centrifugal lesion development from the veins but they did not have access to the dynamic evolution of MS lesions. With the advent of MRI, longitudinal measurements demonstrating that lesions grow centrifugally were acquired6. Recently, vein size modification concomitant to plaque formation was shown9.

Our results suggest that a stenosis of the vein could be observed on SWI at the time of enhancement on post-gadolinium T1. These findings are also supported by another recent study making the hypothesis that the small apparent size of intralesional MS veins may reflect compression by the perivascular inflammatory cuff within active lesions or hardening of the vascular wall in chronic lesions9. Given that the intralesional vein narrowing does reverse at later time points, when the lesion appears larger, it is unlikely that partial-voluming would determine the intravascular hyperintensity.

Our study shows that vein narrowing is an early event that appears to precede blood-brain barrier disruption signified by contrast-enhancement. The observed transient vein narrowing and intraveinous hyperintensity in active lesions is consistent with previous cross-sectional findings9.

CONCLUSION

Intralesional vein stenosis is reversible and consistent with focal hypercellularity in the context of T-cell aggregation during MS lesion formation. Spatiotemporal clustering enables automated detection of venular and lesional changes over time. Our findings are not generalizable due to insufficient spatial resolution, yielding only 3 analyzable lesions. Future work at high temporal and spatial resolution is needed. Nevertheless, our findings are a further step in the understanding of MS plaque formation, and might guide future research into disrupting lesion formation at its earlier stages.

Acknowledgements

This work was funded by CNRS grant PEPS INS2I.

This work was performed within the framework of the LABEX PRIMES (ANR-11-LABX-0063) of Université de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007 / ANR-10-COHO-002) operated by the French National Research Agency (ANR).

References

1. Ge Y, Law M, Herbert J, Grossman RI. Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. AJNR Am J Neuroradiol. 2005;26(9):2316-2319.

2. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004;52:612–618.

3. Cotton F, Weiner HL, Jolesz FA, Guttmann CR. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology. 2003;60(4):640-6.

4. Guttmann CR, Rousset M, Roch JA, Hannoun S, Durand-Dubief F, Belaroussi B, Cavallari M, Rabilloud M, Sappey-Marinier D, Vukusic S, Cotton F. Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study. Mult Scler. 2015;1352458515600247

5. Mure S, Grenier T, Meier DS, Guttmann CRG, Benoit-Cattin H, Unsupervised spatio-temporal filtering of image sequences. A mean-shift specification. Pattern Recognition Letters. 2015;68:48-55.

6. Guttmann CR, Ahn SS, Hsu L, Kikinis R, Jolesz FA. The evolution of multiple sclerosis lesions on serial MR. AJNR Am J Neuroradiol. 1995 Aug;16(7):1481-91.

7. Dawson JD. The histology of disseminated sclerosis. Trans. Roy. Soc. Edinburgh. 1916;50:517-740.

8. McAlpine D, Compston ND, Lumsden CE. Pathology of multiple sclerosis. Edinburgh, E & S Livingstone. 1955;208-239.

9. Gaitán MI, de Alwis MP, Sati P, Nair G, Reich DS. Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins. Neurology. 2013;80(2):145-51.

Figures

Figure 1: 8 time points longitudinal study of the 3 MS lesions and their corresponding classification automatically obtained. The classes in red correspond to pixels sharing the same abnormal temporal behavior (neither lesion nor veins behaviors). Red boxed SWI highlight the time-points of these abnormalities appearances.

Figure 2: SWI mean grey level evolution in ROI A classes. The red arrow indicates time of vein stenosis on SWI; the brown arrow indicates time of first enhancement on contrast-enhanced T1. The blue, purple and golden curves show the evolution of the V/L, lesion core and lesion periphery classes

Figure 3: SWI mean grey level evolution in ROI B classes. The red arrow indicates time of vein stenosis on SWI; the brown arrow indicates time of first enhancement on contrast-enhanced T1. The blue, green and purple curves show the evolution of two V/L classes and the lesion class

Figure 4: SWI mean grey level evolution in ROI C classes. The red arrow indicates time of vein stenosis on SWI; the brown arrow indicates time of first enhancement on contrast-enhanced T1. The blue and purple curves show the evolution of the V/L and lesion classes



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
1290